Kannan S, Murugan AK, Balasubramanian S, Munirajan AK, Alzahrani AS. Gliomas: genetic alterations, mechanisms of metastasis, recurrence, drug resistance, and recent trends in molecular therapeutic options. Biochem Pharm. 2022;201:115090.
Article CAS PubMed Google Scholar
Venkataramani V, Schneider M, Giordano FA, Kuner T, Wick W, Herrlinger U, et al. Disconnecting multicellular networks in brain tumours. Nat Rev Cancer. 2022;22:481–91.
Article CAS PubMed Google Scholar
Tong S, Wang Y, Wu J, Long J, Zhong P, Wang B. Comprehensive pharmacogenomics characterization of temozolomide response in gliomas. Eur J Pharm. 2021;912:174580.
Lang F, Liu Y, Chou FJ, Yang C. Genotoxic therapy and resistance mechanism in gliomas. Pharm Ther. 2021;228:107922.
Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature. 1998;391:357–62.
Article CAS PubMed Google Scholar
Jumpertz S, Hennes T, Asare Y, Schutz AK, Bernhagen J. CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells. Cell Signal. 2017;34:38–46.
Article CAS PubMed Google Scholar
Kim HY, Park JH, Won HY, Lee JY, Kong G. CBX7 inhibits breast tumorigenicity through DKK-1-mediated suppression of the Wnt/beta-catenin pathway. FASEB J. 2015;29:300–13.
Article CAS PubMed Google Scholar
Zhang H, Yu C, Dai J, Keller JM, Hua A, Sottnik JL, et al. Parathyroid hormone-related protein inhibits DKK1 expression through c-Jun-mediated inhibition of beta-catenin activation of the DKK1 promoter in prostate cancer. Oncogene. 2014;33:2464–77.
Article CAS PubMed Google Scholar
Niu J, Li W, Liang C, Wang X, Yao X, Yang RH, et al. EGF promotes DKK1 transcription in hepatocellular carcinoma by enhancing the phosphorylation and acetylation of histone H3. Sci Signal. 2020;13:eabb5727.
Article CAS PubMed Google Scholar
Kimura H, Sada R, Takada N, Harada A, Doki Y, Eguchi H, et al. The Dickkopf1 and FOXM1 positive feedback loop promotes tumor growth in pancreatic and esophageal cancers. Oncogene. 2021;40:4486–502.
Article CAS PubMed PubMed Central Google Scholar
Shen Q, Fan J, Yang XR, Tan Y, Zhao W, Xu Y, et al. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. Lancet Oncol. 2012;13:817–26.
Article CAS PubMed Google Scholar
Chu HY, Chen Z, Wang L, Zhang ZK, Tan X, Liu S, et al. Dickkopf-1: a promising target for cancer immunotherapy. Front Immunol. 2021;12:658097.
Article CAS PubMed PubMed Central Google Scholar
Kikuchi A, Matsumoto S, Sada R. Dickkopf signaling, beyond Wnt-mediated biology. Semin Cell Dev Biol. 2022;125:55–65.
Article CAS PubMed Google Scholar
Salim H, Zong D, Haag P, Novak M, Mork B, Lewensohn R, et al. DKK1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell lines. BMC Cancer. 2015;15:628.
Article PubMed PubMed Central Google Scholar
Zhao Y, Wang C, Goel A. Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancer. Carcinogenesis. 2021;42:814–25.
Article CAS PubMed PubMed Central Google Scholar
Agbarya A, Ruimi N, Epelbaum R, Ben-Arye E, Mahajna J. Natural products as potential cancer therapy enhancers: a preclinical update. SAGE Open Med. 2014;2:2050312114546924.
Article PubMed PubMed Central Google Scholar
Ouyang L, Luo Y, Tian M, Zhang SY, Lu R, Wang JH, et al. Plant natural products: from traditional compounds to new emerging drugs in cancer therapy. Cell Prolif. 2014;47:506–15.
Article CAS PubMed PubMed Central Google Scholar
Zhang H, Li S, Si Y, Xu H. Andrographolide and its derivatives: current achievements and future perspectives. Eur J Med Chem. 2021;224:113710.
Article CAS PubMed Google Scholar
Malik Z, Parveen R, Parveen B, Zahiruddin S, Aasif Khan M, Khan A, et al. Anticancer potential of andrographolide from Andrographis paniculata (Burm.f.) Nees and its mechanisms of action. J Ethnopharmacol. 2021;272:113936.
Article CAS PubMed Google Scholar
Li Y, Zhang P, Qiu F, Chen L, Miao C, Li J, et al. Inactivation of PI3K/Akt signaling mediates proliferation inhibition and G2/M phase arrest induced by andrographolide in human glioblastoma cells. Life Sci. 2012;90:962–7.
Article CAS PubMed Google Scholar
Zhang J, Li C, Zhang L, Heng Y, Wang S, Pan Y, et al. Andrographolide, a diterpene lactone from the Traditional Chinese Medicine Andrographis paniculate, induces senescence in human lung adenocarcinoma via p53/p21 and Skp2/p27. Phytomedicine. 2022;98:153933.
Article CAS PubMed Google Scholar
Bodiga VL, Bathula J, Kudle MR, Vemuri PK, Bodiga S. Andrographolide suppresses cisplatin-induced endothelial hyperpermeability through activation of PI3K/Akt and eNOS -derived nitric oxide. Bioorg Med Chem. 2020;28:115809.
Article CAS PubMed Google Scholar
Yang SH, Wang SM, Syu JP, Chen Y, Wang SD, Peng YS, et al. Andrographolide induces apoptosis of C6 glioma cells via the ERK-p53-caspase 7-PARP pathway. Biomed Res Int. 2014;2014:312847.
Article PubMed PubMed Central Google Scholar
Lu J, Ma Y, Wu J, Huang H, Wang X, Chen Z, et al. A review for the neuroprotective effects of andrographolide in the central nervous system. Biomed Pharmacother. 2019;117:109078.
Article CAS PubMed Google Scholar
Ortiz R, Perazzoli G, Cabeza L, Jimenez-Luna C, Luque R, Prados J, et al. Temozolomide: an updated overview of resistance mechanisms, nanotechnology advances and clinical applications. Curr Neuropharmacol. 2021;19:513–37.
CAS PubMed PubMed Central Google Scholar
Desai R, Suryadevara CM, Batich KA, Farber SH, Sanchez-Perez L, Sampson JH. Emerging immunotherapies for glioblastoma. Expert Opin Emerg Drugs. 2016;21:133–45.
Article CAS PubMed PubMed Central Google Scholar
Cruz JVR, Batista C, Afonso BH, Alexandre-Moreira MS, Dubois LG, Pontes B, et al. Obstacles to glioblastoma treatment two decades after temozolomide. Cancers. 2022;14:3203.
Article CAS PubMed PubMed Central Google Scholar
Vilar JB, Christmann M, Tomicic MT. Alterations in molecular profiles affecting glioblastoma resistance to radiochemotherapy: where does the good go? Cancers. 2022;14:2416.
Article CAS PubMed PubMed Central Google Scholar
Tomar MS, Kumar A, Srivastava C, Shrivastava A. Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance. Biochim Biophys Acta Rev Cancer. 2021;1876:188616.
Article CAS PubMed Google Scholar
Grotewold L, Theil T, Ruther U. Expression pattern of Dkk-1 during mouse limb development. Mech Dev. 1999;89:151–3.
留言 (0)